India's Supreme Court has ruled against Big Pharma and for the country's generic drug companies. But who's the big winner in the end?
China's mysterious pig, duck, and people deaths could be connected. And that should worry us.
Budget hawks' plans to cut funding for political and social science aren't just short-sighted and simple-minded -- they'll actually hurt national security.
International Medical Corps responds to Laura Heaton's investigation of mass rape in a small Congolese town.
The 43rd president of the United States did a great thing for humankind -- but most Americans have no idea.
Esquire's article about "The Shooter" got it wrong, but our veterans' care is still shot.
It’s not Islamic radicals or war that’s killing the poor people of the Sahel. It’s something far simpler.
As winter clutches northern Syria, thousands displaced by the civil war take cold comfort in a temporary tent city.
The world could learn a lot from Brazil's fight against poverty.
Aid workers are caught in the crossfire of Syria's bloody revolt.
With Hugo Chávez in Cuba for yet more medical treatment, will Venezuela fall apart without him?
Contraceptives empower women -- and that's good news for the global health and development agenda.
Man does not live by GDP alone. An introduction to the Legatum Institute's latest Prosperity Index.
India has a problem with substandard drugs -- and American regulators are allowing them to be imported into the United States.
Academic economists usually air their new ideas first in working papers. Here, before the work gets dusty, a quick look at transition policy research in progress.
Libya is trying to build a new democracy. But that's a tall order for a society plagued by bad memories.
Al Jazeera's new investigation into the not-so-mysterious death of Palestinian leader Yasir Arafat is little more than baseless speculation.
The Supreme Court's ruling was a step in the right direction. But spiraling health-care costs could still doom America's recovery.